What Is MOTS-c? Benefits of the “Exercise Mimetic” Peptide

MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA that cells release during metabolic stress. In animal studies, giving MOTS-c improved insulin sensitivity, exercise endurance, heart function and bone strength, leading scientists to call it an “exercise mimetic.” No clinical trials have yet tested MOTS-c in people, so its long-term safety and optimal dose remain unknown. Under the FDA’s 2026 interim access policy, doctors may now prescribe patient-specific compounded MOTS-c from qualified 503A pharmacies, and Rx.com plans to offer prescription compounded MOTS-c soon.

• MOTS-c stands for “mitochondrial open reading frame of the 12S rRNA type-c,” a peptide released when cells are under energetic stress. (Zheng et al., 2023)
• A single MOTS-c injection boosted running time by 12 % and distance by 15 % in mice during an acute exercise test. (Hyatt, 2022)
• Long-term MOTS-c treatment improved blood sugar control and reduced cardiac fibrosis in diabetic rodent models. (Li et al., 2026)
• Levels of MOTS-c rise in human skeletal muscle and blood after high-intensity exercise, suggesting it helps coordinate training adaptations. (Woodhead et al., 2021)
• No human safety studies have been published, and the peptide is not FDA-approved; compounded MOTS-c is allowed only under the interim enforcement-discretion policy.
• Rx.com plans to offer prescription compounded MOTS-c through U.S.-licensed providers and a 503A pharmacy (coming soon).

What MOTS-c Is and How It Works

MOTS-c is a mitochondrial-derived peptide (MDP): a 16-amino-acid chain encoded by a short open reading frame inside the 12S rRNA region of mitochondrial DNA. When cells face metabolic stress-such as intense exercise, nutrient deprivation, or oxidative stress-MOTS-c translocates to the nucleus and turns on genes that boost cellular energy production and antioxidant defenses. (Zheng et al., 2023)

This retrograde signaling (communication from mitochondria back to the nucleus) helps cells adapt quickly to energy challenges: increasing glucose uptake, activating AMPK, shifting fuel use toward fatty-acid oxidation, and reducing reactive oxygen species. (Türkel et al., 2022)

MOTS-c is detected in muscle, fat, bone, and the bloodstream, but levels decline with age, which may partly explain why older adults adapt less robustly to exercise. (Zheng et al., 2023) MOTS-c

Why Scientists Call MOTS-c an Exercise Mimetic

Exercise sharply raises MOTS-c inside working muscles and in circulation, and delivering extra MOTS-c to sedentary animals reproduces several hallmark exercise adaptations. In one mouse study, voluntary wheel running for eight weeks increased muscle MOTS-c protein 1.5- to 5-fold compared with sedentary controls. (Hyatt, 2022)

Key exercise-like pathways switched on by MOTS-c include:

• AMP-activated protein kinase (AMPK): the same energy sensor triggered by endurance training, promoting fatty-acid oxidation and glucose uptake. (Türkel et al., 2022)
• NRF2 antioxidant response: helping neutralize exercise-induced oxidative stress. (Fasipe et al., 2023)
• PGC-1α mitochondrial biogenesis: leading to more efficient energy production in muscle. (Woodhead et al., 2021)

Because it induces these pathways without physical movement, researchers group MOTS-c with other “exerkines”-molecules released during physical activity that may explain exercise’s systemic health benefits. (Türkel et al., 2022) Learn how the FDA looks at exercise-mimetic peptides

Potential Benefits Seen in Animal Studies

So far, every MOTS-c benefit comes from rodent or cell experiments, not from randomized human trials. Still, the results outline intriguing possibilities:

Is MOTS-c anti-aging? Some early work links falling MOTS-c levels to age-related frailty, while supplementation in older mice improved physical performance. (Hyatt, 2022) However, other research suggests mitochondrial peptides might worsen cellular senescence markers, highlighting a complex picture. (Mendelsohn et al., 2018)

What We Know (and Don’t) About MOTS-c in Humans

Evidence in people is limited to observational studies measuring natural MOTS-c spikes after exercise. A 2021 review reported that high-intensity cycling increased plasma MOTS-c immediately post-workout, supporting its role as an exercise signal. (Woodhead et al., 2021) No published clinical trial has delivered synthetic MOTS-c to volunteers, so:

• Optimal dose and schedule: Unknown.
• Safety profile: Unknown. Potential risks could include immune reactions, hypoglycemia, or off-target growth effects.
• Drug interactions: Unknown. Because MOTS-c activates AMPK like metformin, overlapping mechanisms could exist.

Until peer-reviewed human data emerge, experts classify MOTS-c as experimental. Any use should occur under a licensed prescriber who can monitor labs and side effects. See how online peptide prescriptions work

How You Can Legally Access Compounded MOTS-c Today

MOTS-c is not an FDA-approved drug, but physicians in the United States may now order a patient-specific compounded version. In July 2026, the FDA’s Pharmacy Compounding Advisory Committee recommended MOTS-c for enforcement discretion despite staff objections, and HHS published the “Interim Access Policy for Compounding Using Certain Peptides.” The policy states FDA does not intend to take action against state-licensed 503A pharmacies that compound MOTS-c for an individual on a prescription, as long as they meet requirements for ingredient quality, manufacturing standards, labeling, and adverse-event reporting.

Key points of the interim policy:

• Applies only to six peptides: BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon.
• Does not add these peptides to the official 503A bulks list and does not equal FDA approval.
• States may choose not to follow the policy, so local regulations can differ.
• “Research use only” products sold online remain outside the policy and unregulated.

Rx.com plans to offer prescription compounded versions of these peptides (coming soon), prescribed online by U.S.-licensed providers and dispensed by a certified 503A pharmacy. When the service launches, you will be able to explore treatment options at prescription peptides from Rx.com.

Safety Tips Before Considering MOTS-c

Because no human dosing guidance exists, decisions must be individualized. Your prescriber may discuss off-label use only after reviewing your medical history and goals. To have an informed conversation, consider these points:

Health conditions: If you have diabetes, heart disease, cancer, or are pregnant or breastfeeding, you may face additional risks because MOTS-c affects metabolism and growth pathways.

Monitoring plan: Ask what labs or imaging your provider will order (for example, fasting glucose, liver enzymes, echocardiogram) and how often.

Source transparency: Verify that the pharmacy is state-licensed, uses USP-grade ingredients, and participates in adverse-event reporting as required under the interim policy.